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ARTICLE
Siderophore-mediated zinc acquisition enhances
enterobacterial colonization of the inflamed gut
Judith Behnsen 1,2,15, Hui Zhi3,15, Allegra T. Aron4,5, Vivekanandan Subramanian6, William Santus 2,
Michael H. Lee3, Romana R. Gerner3, Daniel Petras 4,5, Janet Z. Liu 1, Keith D. Green7, Sarah L. Price8,
Jose Camacho3, Hannah Hillman3, Joshua Tjokrosurjo1, Nicola P. Montaldo1, Evelyn M. Hoover1,
Sean Treacy-Abarca1, Benjamin A. Gilston9, Eric P. Skaar 10, Walter J. Chazin 9, Sylvie Garneau-Tsodikova7,
Matthew B. Lawrenz 11, Robert D. Perry12, Sean-Paul Nuccio1,3, Pieter C. Dorrestein 4,5,13 &
Manuela Raffatellu 1,3,13,14✉
Zinc is an essential cofactor for bacterial metabolism, and many Enterobacteriaceae express
the zinc transporters ZnuABC and ZupT to acquire this metal in the host. However, the
probiotic bacterium Escherichia coli Nissle 1917 (or “Nissle”) exhibits appreciable growth in
zinc-limited media even when these transporters are deleted. Here, we show that Nissle
utilizes the siderophore yersiniabactin as a zincophore, enabling Nissle to grow in zinc-limited
media, to tolerate calprotectin-mediated zinc sequestration, and to thrive in the inflamed gut.
We also show that yersiniabactin’s affinity for iron or zinc changes in a pH-dependent
manner, with increased relative zinc binding as the pH increases. Thus, our results indicate
that siderophore metal affinity can be influenced by the local environment and reveal a
mechanism of zinc acquisition available to commensal and pathogenic Enterobacteriaceae.
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The Enterobacteriaceae are a diverse family of bacteria thatinhabit the gastrointestinal tract. Members of this groupinclude the enteric pathogen Salmonella enterica serovar
Typhimurium (S. Typhimurium, or STm), as well as Escherichia
coli, a species that comprises myriad commensals, pathobionts,
and pathogens. Both STm and E. coli can colonize the intestine of
mammals and thrive in inflammatory conditions1–5. During
homeostasis, the gut microbiota is primarily composed of
obligate anaerobes belonging to the phyla Bacteroidetes and
Firmicutes6. In the inflamed gut, however, the oxidative envir-
onment suppresses obligate anaerobes and favors the growth of
facultative anaerobes, which include pathogenic and commensal
Enterobacteriaceae1,2,4,5,7,8.
One mechanism that enables enterobacterial growth in the
inflamed gut is the ability to scavenge metal nutrients. Many
biological processes including DNA replication, transcription,
respiration, and oxidative stress responses require iron, manga-
nese, cobalt, nickel, copper, and/or zinc9. Iron is one of the
most abundant transition metal ions in living organisms, and
serves as an essential cofactor in central metabolism and
respiration10,11. The other most abundant metal ion is zinc,
which is a cofactor for an estimated 5–6% of all proteins12, and
whose functions include acting as the catalytic center in enzymes
such as metalloproteases, superoxide dismutases, and metallo-β-
lactamases. Thus, bacteria must be able to acquire sufficient
amounts of both iron and zinc in order to survive and replicate in
a given environment.
Bacteria living inside the human host face particular difficulties in
obtaining these metal nutrients. During homeostasis, the availability
of such metal ions is actively limited by the host and by the resident
microbiota. Moreover, nutrient metal availability is further restricted
during inflammation in a process termed “nutritional immunity”13,
wherein the host secretes antimicrobial proteins that sequester iron,
zinc, and manganese from microbes to limit their growth. We have
previously shown that the pathogen STm overcomes host nutri-
tional immunity by obtaining iron, zinc and manganese in the
inflamed gut1,14–16. In response to iron limitation, STm secretes
enterobactin and salmochelin, which are small iron-scavenging
molecules called siderophores17,18. In response to zinc limitation,
STm expresses the high-affinity zinc transporter ZnuABC15,19,20.
STm also expresses the ZupT permease, which transports zinc and
other divalent metal ions21,22. Independently, each of these trans-
porters has been shown to contribute to STm virulence in mouse
models of infection15,19,20,23,24.
High-affinity zinc acquisition systems enable microbes to
overcome zinc sequestration by the host protein calprotectin
(CP), a heterodimer of the S100A8 and S100A9 proteins25. CP
constitutes up to 40% of neutrophil cytosolic content26, and the
expression of its two subunits can be induced in epithelial cells
following stimulation with IL-17 and IL-221,27. In the inflamed
gut, expression of ZnuABC enables STm to overcome CP-
mediated zinc sequestration, outcompete the microbiota, and
colonize to high levels1,15.
In addition to STm, other Enterobacteriaceae can thrive in the
inflamed intestine. One such example is the probiotic bacterium
Escherichia coli Nissle 1917 (E. coli Nissle, or EcN), a strain that
was first isolated in WWI from the stool of a soldier who did not
develop gastroenteritis during a Shigella outbreak28. Since then,
EcN has proven to be effective in the treatment and prevention of
intestinal disorders including chronic constipation, ulcerative
colitis, and infantile diarrhea29–32, albeit its mechanisms of action
are not well understood. Our previous work has demonstrated
that EcN reduces STm colonization in mouse models of gastro-
enteritis by utilizing multiple iron uptake systems and by
secreting antimicrobial proteins known as microcins to out-
compete the pathogen3,33.
In this work, we show that an EcN strain lacking ZnuABC and
ZupT is still able to grow appreciably in zinc-limited media,
leading us to discover that EcN expresses an additional means of
acquiring zinc. Using our recently developed native spray meta-
bolomics approach34, we find that the siderophore yersiniabactin
(Ybt) produced by EcN is capable of binding zinc, and that EcN
utilizes Ybt as a zincophore. Moreover, we demonstrate that EcN
utilizes Ybt, in addition to the zinc transporters ZnuABC and
ZupT, to effectively acquire zinc in vitro, to tolerate the anti-
microbial activity of CP, and to colonize the inflamed gut.
Results
E. coli Nissle is more resistant to calprotectin-mediated zinc
sequestration than S. Typhimurium. We have previously shown
that multiple iron uptake systems enable EcN to colonize the
inflamed gut and to compete with STm33. As zinc is also limited
in the inflamed gut, we hypothesized that EcN must also have
robust mechanisms for acquiring this metal. We thus compared
the growth of EcN to the growth of STm in a rich medium
supplemented with CP, a host antimicrobial protein that
sequesters zinc and limits its availability to microbes15,25. To this
end, we employed CP concentrations (125–250 μg/ml) compar-
able to those found in the inflamed gut15. EcN and STm showed
similar growth in rich media without the addition of CP, but EcN
grew significantly better than STm in media supplemented with
CP (Fig. 1a and Supplementary Fig. 1a–c). Thus, EcN is more
resistant than STm to the antimicrobial activity of CP in vitro and
prompted us to investigate the underlying mechanism.
Both EcN and STm encode two known zinc transport systems:
the high-affinity zinc transporter ZnuABC and the permease
ZupT15,19,20,23,24. Although the function of these two transporters
in EcN has not been directly investigated, their disruption
significantly diminishes the capacity of the closely-related
uropathogenic E. coli strain CFT073 to grow in zinc-depleted
culture media and to cause urinary tract infection35. To
determine whether the difference in CP-resistance between EcN
and STm is the result of variations related to ZnuABC and ZupT,
we disrupted these transporters in both EcN and STm by deleting
the genes znuA and zupT. As expected, both mutant strains (EcN
znuA zupT and STm znuA zupT) grew slower than their
respective parental strains in the presence of CP, but not in the
presence of a Site I/II knockout mutant CP (MU CP; lacks the
ability to bind zinc)36,37, or when ZnSO4 was added to the media
(Fig. 1b and Supplementary Fig. 1d, e). These results indicated
that ZnuABC and ZupT have similar functions in both EcN and
STm, and mediate evasion of CP-dependent antimicrobial
activity.
Puzzlingly, we observed that the EcN znuA zupT mutant grew
up to 1000-fold better than the STm znuA zupT mutant in the
presence of 125–150 μg/ml CP (Fig. 1b and Supplementary
Fig. 1e). Although higher concentrations of CP (250 μg/ml)
reduced the growth of the EcN znuA zupT mutant, it was still
100-fold higher than the STm znuA zupT mutant (Fig. 1c). As the
addition of ZnSO4 rescued the growth of both the EcN and STm
znuA zupT mutants (Supplementary Fig. 1f), we posited that EcN
acquires zinc via an additional mechanism absent in STm.
A product of the yersiniabactin operon promotes zinc acqui-
sition by E. coli Nissle in zinc-limited media. In iron-limiting
conditions, EcN acquires iron by producing the siderophores
enterobactin, salmochelin, aerobactin, and yersiniabactin (Ybt)33.
Although the importance of siderophores in scavenging iron has
been well-demonstrated in biological systems, chemists have
known for decades that some siderophores can bind other metals
besides iron (reviewed in Johnstone and Nolan38). Among the
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siderophores produced by EcN, Ybt has been shown to also bind
copper, gallium, nickel, cobalt, and chromium39. Intriguingly, a
product of the Ybt gene cluster has been proposed to contribute
to zinc acquisition by the pathogen Yersinia pestis40,41; however,
its identity and mechanism are unknown, as two prior studies did
not provide evidence of direct zinc binding by Ybt39,41. We thus
sought to determine whether, in addition to ZnuABC and ZupT,
EcN uses a product of the Ybt operon to acquire zinc under zinc-
limiting conditions.
To this end, we deleted the ybt cluster’s irp2 gene that encodes
the synthetase HMWP2, thus rendering EcN unable to synthesize
Ybt42–44. We also deleted the ybtX gene, which encodes for an
inner membrane permease that, in Y. pestis, was found to be
dispensable for iron uptake, but required for zinc uptake, as a znu
ybtX mutant is unable to grow in zinc-limited medium40,41. Of
note, the first published genome sequence of EcN wild-type
(GenBank CP007799.1, Reister et al.45) indicated that irp1 and
irp2 were disrupted (frameshifted and insertion sequence,
respectively), although a recent sequencing effort utilizing our
lab’s EcN wild-type strain revealed these genes to be intact
(GenBank “CP022686.1”), which is consistent with a prior study
showing that EcN produces Ybt46. Next, we tested the growth of
EcN strains lacking these genes, in addition to the znuA zupT
genes, in metal-limiting conditions (M9 minimal medium).
Strains lacking znuA zupT and either irp2 or ybtX displayed a
severe growth defect in M9 minimal medium, where the strains
grew 1000-fold less than EcN wild-type and more than 10-fold
less than EcN znuA zupT (Fig. 1d). Furthermore, growth of all
mutants was restored in ZnSO4-supplemented M9 minimal
medium (Supplementary Fig. 1g) and in LB broth without metal
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limitation (Supplementary Fig. 1h). Moreover, only zinc supple-
mentation, but not iron or nickel supplementation, restored
growth of the mutants to wild-type levels (Fig. 1e, f), confirming
that the observed growth defects of the mutants were indeed due
to zinc deficiency. Taken together, these results suggested that a
product of the ybt gene cluster contributes to zinc acquisition by
the probiotic EcN in zinc-limited media. We therefore hypothe-
sized that the Ybt locus may encode for the production of a
zincophore.
Yersiniabactin is a zincophore. To identify whether the ybt gene
cluster produces a zincophore, we cultured EcN wild-type and the
irp2 mutant in M9 minimal media and collected culture pellets
and supernatants to then run ultra-high performance liquid
chromatography tandem mass spectrometry (UHPLC-MS/MS).
In addition to running UHPLC-MS/MS metabolomics on these
samples, we performed experiments using post-liquid chroma-
tography (LC) pH adjustment to 6.8 and infusion of a zinc acetate
solution, followed by mass spectrometry – a workflow that we
term native electrospray metabolomics – in order to assess
whether any of the metabolites produced were capable of binding
zinc34. This native metabolomics strategy is then combined with
ion identity-based molecular networking, a new computational
and data visualization strategy that allows for the discovery of
mass spectrometry features with the same retention time and
specified mass offsets34; mass spectrometry features with the same
retention time and a mass difference resulting from zinc binding
can be discovered directly from complex metabolomics samples.
Using this native electrospray metabolomics workflow, a
number of zinc-binding small molecules were observed in the
wild-type supernatant samples (Fig. 2a, b); zinc-bound nodes
(each node represents an MS1 feature and its clustered MS/MS
spectra) are shown in salmon and are connected to protonated
nodes (dark blue) with a blue dashed line (indicating a m/z
delta= [Zn2+-H+]+) (Fig. 2a, b). Furthermore, two peaks were
observed in culture supernatant (Fig. 2c) from EcN wild-type that
were absent in the irp2 mutant cultured in M9 minimal media
(Fig. 2c). Feature-based molecular networking using MZmine in
conjunction with Global Natural Products Social (GNPS)
Molecular Networking47,48 allowed us to putatively identify these
two peaks as Ybt. Ybt is known to tautomerize at C10 (Fig. 3), so
exists as two diastereomers49. We confirmed that these peaks
were two diastereomers of Ybt by matching the retention time,
exact mass, and MS/MS spectra acquired from culture extracts to
an authentic Ybt standard (Fig. 2e, f). Post-LC pH neutralization
and zinc-infusion revealed the zinc-bound Ybt species, indicating
that Ybt is indeed capable of binding zinc (Fig. 2d). To our
surprise, we also found that one of the diastereomers (at retention
time= 4.0 min) seems to bind zinc with higher preference than
the other (at retention time= 4.3 min) (Fig. 2d). Since Ybt was
initially discovered as an iron-binding molecule, and thus termed
a siderophore, we next sought to determine the preferential
conditions for binding iron versus zinc. To assess the competition
between iron and zinc binding, we performed direct infusion
mass spectrometry competition experiments at multiple pH
values. In these experiments, we added equimolar amounts of
zinc and iron to Ybt in ammonium acetate buffer adjusted to pH
4, 7, and 10. While Ybt preferentially binds iron at low pH (pH 4),
it exhibits a higher preference for zinc at high pH (pH 10)
(Fig. 2g). These experiments suggest that Ybt-Zn2+ binding is
most competitive to ferric iron binding at basic pH; however,
another possible explanation is that less ferric iron than Zn2+ is
available to bind at basic pH due to solubility differences between
the two metals. Nevertheless, at neutral pH (pH 7), Ybt was
observed bound to iron or zinc at roughly equal proportion
(Fig. 2g).
To confirm the zinc-binding observed by native electrospray
metabolomics, we monitored a zinc-titration into Ybt by 1D 1H
NMR (Fig. 3). Although Ybt is in equilibrium between two
tautomers at C10 that seem to have different relative affinities for
zinc, only one set of signals is observed in the spectra. This same
observation was reported in earlier studies of gallium binding to
Ybt49. The addition of zinc modulates a number of signals,
including those of the NH proton and the two hydroxyl proton
peaks at ~11.6, 10.0, and 8.4 ppm. The intensity of these well-
resolved peaks decreases progressively upon addition of 0.5 and
1.0 equivalents of zinc, which is consistent with the nitrogen
(N10-12) and oxygen (O1 and O13) heteroatoms chelating the
zinc atom (Fig. 3), in a manner similar to Ybt binding of iron50
and copper51, and zinc binding by the Pseudomonas sp.-derived
compound micacocidin A52. Finally, we found that increasing the
pH of the solution via addition of 0–5 molar equivalents of NaOD
had little effect on the NMR spectrum of zinc-bound Ybt
complex, aside from the exchange of labile hydrogens with
deuterium (Supplementary Fig. 2), showing that zinc is bound in
the same manner across a broad range of pH. Given that zinc-Ybt
complexes were observed using native electrospray metabolomics,
and this was confirmed by NMR, we next assessed Ybt-zinc
binding in the presence of CP. In competition experiments, we
observed that CP exchanges zinc with Ybt even when Ybt-zinc
was pre-formed, while the Site I/II knockout mutant CP (MU CP)
does not participate in this exchange (Supplementary Fig. 3).
Thus, CP can outcompete Ybt for zinc, consistent with the results
from growth assays with WT and MU CP (Fig. 1). However, this
Fig. 1 E. coli Nissle resistance to calprotectin-mediated zinc limitation in vitro is dependent on ZnuABC, ZupT, and yersiniabactin. a E. coli Nissle (EcN)
and S. Typhimurium (STm) wild-type were grown in modified LB medium without calprotectin (CP), or supplemented with 150 µg/ml or 250 µg/ml CP.
Statistics: two-way ANOVA with Šidák’s multiple comparisons test. b EcN and STm znuA zupTmutants were grown in modified LB medium without CP (No
CP), or supplemented with 150 µg/ml CP, 150 µg/ml Site I/II knockout mutant CP (MU CP), or 150 µg/ml CP plus 5 µM ZnSO4 (CP+ ZnSO4). Statistics:
two-way ANOVA with Šidák’s multiple comparison test. c EcN and STm wild-type and znuA zupT mutants were grown in modified LB medium
supplemented with 250 µg/ml CP. Statistics: one-way ANOVA with Tukey’s multiple comparisons test. d EcN and STm znuA zupT mutants, as well as EcN
triple mutants (znuA zupT irp2; znuA zupT ybtX), were grown in modified LB without CP, or supplemented with either 150 µg/ml mutant CP (MU 150), or
with 150 µg/ml (150) or 250 µg/ml CP (250). Statistics: two-way ANOVA with Tukey’s multiple comparisons test. e, f EcN wild-type, double (znuA zupT)
and triple (znuA zupT irp2; znuA zupT ybtX) mutants were grown in M9 medium (n= 3 biologically independent replicates) or in M9 supplemented with
either 5 µM ZnSO4 (n= 3 biologically independent replicates), 5 µM FeCl2 (n= 5 biologically independent replicates), or 5 µM NiCl2 (n= 5 biologically
independent replicates). g EcN wild-type and indicated double and triple mutants were grown in M9 medium or in M9 supplemented with either 1 µM
yersiniabactin (Ybt) or enterobactin (Ent). Statistics: one-way ANOVA with Tukey’s multiple comparisons test. a–g Growth was quantified by enumeration
of bacterial CFU on selective media after a–d 16 h static, e, f 8 h and 24 h shaking, or g 20 h shaking incubation. Data are representative of three
independent experiments. a–d, g Bars represent the geometric mean. The number (=n) of biologically independent replicates for each group is indicated in
each figure panel. e, f Data are presented as geometric mean values ± geometric SD. *P value≤ 0.05; **P value≤ 0.01; ***P value≤ 0.001, ****P
value≤ 0.0001; ns not significant. Exact P values are reported in Supplementary Data 2. Source data are provided as a Source Data file.
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does not rule out the possibility that Ybt may be able to scavenge
the remaining zinc that is not bound by CP, akin to other zinc
acquisition systems in bacteria.53
Having now discovered that Ybt can bind zinc in a
physiologically relevant pH range, even in the presence of iron,
we next tested whether the addition of exogenous Ybt could
rescue the growth of an EcN strain that is highly susceptible to
zinc limitation due to mutations in ZnuABC, ZupT, and Ybt
synthesis (znuA zupT irp2 mutant). Consistent with our
hypothesis, supplementation of M9 minimal media with 1 μM
purified apo-Ybt (Ybt not bound to iron) rescued the growth of
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zupT mutant (Fig. 1g). Furthermore, the growth of a strain
deficient in the putative zinc-transporting inner membrane
protein YbtX (znuA zupT ybtX) was not significantly rescued
by exogenous apo-Ybt (Fig. 1g). Addition of the siderophore apo-
enterobactin, which is not expected to bind to zinc, did not
significantly rescue the growth of either the znuA zupT irp2
mutant or the znuA zupT ybtX mutant (Fig. 1g). Thus, our results
demonstrate that Ybt binds to both iron and zinc, that metal
binding can be influenced by pH, and that Ybt can scavenge zinc
for EcN in zinc-limited media. Next, we assessed whether Ybt
enables EcN to evade the host response.
E. coli Nissle’s higher resistance to calprotectin is due to
yersiniabactin-mediated zinc acquisition. In the host, zinc
limitation is largely dependent on the antimicrobial protein CP54.
We thus tested whether Ybt-mediated zinc acquisition enhances
EcN’s growth in CP-supplemented rich media. Above, we
demonstrated that when the ZnuABC and ZupT transporters
were deleted (znuA zupT mutants), EcN grew better than STm
(Fig. 1b–d). When either irp2 or ybtX were additionally deleted in
EcN, growth of the znuA zupT irp2 and the znuA zupT ybtX
mutants were ~8-fold lower than the parental EcN znuA zupT
strain in the presence of 150 µg/ml CP (Fig. 1d). Although the
growth of EcN znuA zupT was further diminished in the presence
of 250 µg/ml CP, the growth of the EcN znuA zupT irp2 mutant
was again ~10-fold lower, and now comparable to that of the
STm znuA zupT mutant (Fig. 1d). These results are consistent
with Ybt scavenging zinc for EcN when the metal is limited by
CP. Because growth of the EcN znuA zupT ybtX mutant was
similar to the znuA zupT mutant in media supplemented with
250 µg/ml CP, it is possible that zinc-bound Ybt can also be
internalized via a YbtX-independent mechanism. To confirm that
Fig. 2 Yersiniabactin is produced by E. coli Nissle and directly binds zinc in a pH-dependent manner. a, b Native spray metal metabolomics was used to
identify zinc-binding small molecules present in isolated EcN supernatant extracts. Zinc-binding molecules, including Ybt and other truncations, are
concentrated in the boxed molecular families enlarged in panel b. Zinc-binding small molecules are observed when post-LC infusion of Zn2+ and post-pH
adjustment are performed. Zinc-bound molecules are shown in salmon, while the corresponding protonated (Apo) form of these molecules is shown in
dark blue. Structures and molecular formulas (generated using SIRIUS 4.078) are provided. c Extracted ion chromatogram (XIC) for apo-Ybt ([M+H+]
+= 482.1236) is observed as two peaks (present at 4.0 and 4.3 m) in wild-type EcN supernatant (WT extract); tautomerization occurring at C10 results in
the racemic mixture (Fig. 3). When post-LC pH adjustment and Zn2+-infusion are performed, the majority of the peak at 4.3 remains apo-Ybt (WT extract,
+Zn). Neither apo-Ybt peak is present in the EcN irp2 knockout supernatant (irp2 extract). Commercial Ybt (commercial std) also elutes with a minor peak
at 4.0 and a major peak at 4.3 m. d Zn2+-bound Ybt ([M+ Zn2+-H+]+= 544.0371) is not observed in the XIC of wild-type samples (WT extract), in irp2
knockout samples (irp2 extract), or in the commercial standard (commercial std) when the standard LC-MS/MS method is applied; however, when native
spray metal metabolomics is applied (WT extract, +Zn; post-LC infusion of Zn2+ in conjunction with pH neutralization), Zn2+-bound Ybt is observed
([M+ Zn2+-H+]+= 544.0371) as the major species in the first peak (at retention time= 4.01 m). e, f Mirror plots show that peaks present at e 4.0min
and f 4.3 min (black; MS/MS of [(M+ 2H+)/2= 241.5654) both match the MS/MS from commercial Ybt standard (green). g Metal competition data for
direct injection experiments run at pH 4, 7, and 10, in which Ybt was added to buffer in the presence of both iron and zinc; n= 3 biologically independent
replicates). The ratio of extracted peak area of Zn2+-bound Ybt ([M+ Zn2+-H+]+= 544.0371) to extracted peak area of Fe3+-bound Ybt ([M+ Fe3+-H


















































Fig. 3 1D 1H NMR confirms direct zinc binding to yersiniabactin. 1D 1H NMR spectra of Ybt dissolved in CD3CN (top trace, 0 equivalents of Zn, red trace)
as increasing zinc is titrated into the solution (0.5 equiv., gray trace), (1.0 equiv., blue trace). The loss of intensity of the NH and OH signals arises from the
coordination of zinc by the corresponding N and O atoms; the signals that shift correspond to protons whose electronic environment changes due to
binding of the Zn2+ ion. Only partial binding is observed because Ybt is in rapid equilibrium between two tautomers at C10 in addition to hydrolysis that
occurs at C10 49.
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the growth defect of the EcN znuA zupT irp2 mutant is due
to zinc chelation by CP, we supplemented the medium with
150 µg/ml of CP Site I/II knockout mutant (Fig. 1d), or
with 150 µg/ml CP and 5 µM ZnSO4 (Supplementary Fig. 1f). In
both experiments, all strains grew to the same level. Taken
together, these results indicate that Ybt-mediated zinc acquisition
enhances EcN resistance to zinc limitation induced by CP and
provide a mechanistic explanation for EcN’s heightened resis-
tance to zinc limitation relative to STm.
Yersiniabactin enhances E. coli Nissle colonization of the
inflamed gut. After demonstrating that Ybt promotes EcN
resistance to CP in vitro, we next sought to investigate whether
Ybt confers a growth advantage to EcN during inflammatory
conditions in vivo, where CP is highly expressed1,15 and zinc is
limited15. To induce intestinal inflammation, we employed the
dextran sodium sulfate (DSS) mouse colitis model (Fig. 4a). After
4 days of DSS administration, we orally inoculated the mice with
a 1:1 mixture of EcN wild-type and znuA zupT, or of EcN wild-
type and one of the EcN triple mutants (znuA zupT irp2 or znuA
zupT ybtX). EcN wild-type exhibited a significant competitive
advantage over all of the mutants beginning at day 1 post-
inoculation, which substantially increased by day 7, particularly
for the triple mutants (Fig. 4b, d and Supplementary Fig. 4a–c).
Specifically, at day 7 EcN wild-type outcompeted the znuA zupT
mutant an average of ~23-fold, the znuA zupT irp2 mutant an
average of ~13,684-fold, and the znuA zupT ybtX mutant an
average of ~767-fold. These results indicated that ZnuABC and
ZupT are needed for optimal colonization of the inflamed gut,
and that deletion of Ybt genes exacerbates the growth defect of
the znuA zupT mutant in vivo. To further probe the specific role
of Ybt, we performed a second set of competitive experiments, in
which we orally inoculated DSS-treated mice with a 1:1 mixture
of EcN znuA zupT and one of the EcN triple mutants (znuA zupT
irp2 or znuA zupT ybtX). Here, EcN znuA zupT showed a sig-
nificant competitive advantage over both triple mutants, which
increased over time up to ~26-fold (znuA zupT ybtX mutant) and
~45-fold (znuA zupT irp2 mutant) (Fig. 4c, d). In both cases, the
increased competitive advantage was due to the decreased colo-
nization level of the triple mutants, as the znuA zupT mutant
colonized at similar levels (Supplementary Fig. 4d, f). Of note,
host antimicrobial gene expression levels (Lcn2, S100a8, S100a9)
were similarly upregulated in all DSS-treated mice (Fig. 4e), and
all DSS-treated mice developed similar levels of colitis, as shown
by histopathology evaluation of the distal colon (Fig. 4f, g).
Collectively, these results indicate that both Ybt production (via
Irp2) and Ybt transport (via YbtX) enhance EcN colonization of
the inflamed gut. Because Ybt production and acquisition con-
ferred a colonization advantage to the znuA zupT mutant, these
data support the idea that Ybt can scavenge zinc in vivo, in zinc-
limited conditions such as those found in the inflamed gut.
Inflammation and calprotectin are necessary for yersiniabactin
to enhance gut colonization by E. coli Nissle. Next, we ascer-
tained whether the zinc transport systems of EcN play a sig-
nificant role in the absence of gut inflammation. As EcN
colonization levels decline over time in conventional mice in the
absence of inflammation, we used germ-free mice (Fig. 5a), in
which we previously observed high levels of EcN colonization for
extended periods of time3. When we inoculated germ-free mice
with a 1:1 mixture of EcN znuA zupT and either znuA zupT irp2
(Fig. 5b) or znuA zupT ybtX (Fig. 5c), we recovered similar
amounts of each strain from mouse feces throughout the
experiment (Fig. 5b, c and Supplementary Fig. 5a, b). Whereas
S100a8, S100a9, and Lcn2 were highly expressed in the ceca of
DSS-treated animals colonized with EcN, these genes were only
minimally upregulated (< 10-fold) in germ-free mice colonized
with EcN (Fig. 5d). The absence of inflammation in EcN-colo-
nized germ-free mice was also confirmed by colon pathology
(Fig. 5i and Supplementary Fig. 5e).
To further probe whether Ybt provides a means for EcN to
evade CP-dependent zinc depletion in vivo, we employed
S100a9−/− mice (deficient in CP) treated with DSS (Fig. 5e),
and inoculated them with a 1:1 mixture of EcN znuA zupT and
either znuA zupT irp2 (Fig. 5f) or znuA zupT ybtX (Fig. 5g). We
recovered similar amounts of each strain from these mice lacking
CP (Fig. 5f, g and Supplementary Fig. 5c, d) even though the mice
developed intestinal inflammation, as indicated by high expres-
sion levels of pro-inflammatory genes Lcn2, Il17a, Tnfa, and Ifng
(Fig. 5h) and by analysis of colon pathology (Fig. 5i and
Supplementary Fig. 5e). Our results thus indicate that Ybt confers
a colonization advantage to EcN in the inflamed gut, by enabling
EcN to evade CP-dependent zinc sequestration.
Discussion
Commensal and pathogenic Enterobacteriaceae exploit host
inflammation to achieve high levels of colonization and out-
compete obligate anaerobes; these mechanisms include the ability
to utilize alternative electron acceptors that become available
following the production of reactive oxygen and nitrogen species
by activated host cells5,7, as well as new nutrient sources such as
lactate55 and acidic sugars56. In addition to taking advantage of
new metabolic resources, Enterobacteriaceae must also overcome
host-mediated mechanisms of nutritional immunity13, including
metal ion starvation57.
We have previously shown that pathogenic STm and probiotic
EcN evade lipocalin-2-mediated iron sequestration in the
inflamed gut via the production of stealth siderophores16,33. As
we have found that STm also evades CP-mediated zinc seques-
tration in the inflamed gut15, we sought to investigate whether
EcN also evades CP to acquire zinc and thrive in the host. As
EcN, akin to STm, expresses ZnuABC and ZupT, we initially
hypothesized that these zinc transporters mediate EcN resistance
to CP. However, when we found that an EcN znuA zupT mutant
still grew up to 1000-fold better than an STm znuA zupT mutant
in media containing CP (Fig. 1), we speculated that EcN must
utilize additional mechanisms to acquire zinc. In the work pre-
sented herein, we unexpectedly discovered that EcN scavenges
zinc with the siderophore Ybt.
Ybt is a phenolate siderophore that was first discovered as
being produced by Yersinia enterocolitica58. The term side-
rophore has its origin in the Greek language and means “iron
carrier”, as these molecules are widely characterized as being
produced by microorganisms to acquire iron. However, recent
studies have proposed that at least some siderophores may also
bind to other metals. For example, the siderophore ferrioxamine
was shown to bind manganese59,60, and Ybt was shown to bind
copper as a means to evade toxicity61 and to scavenge copper and
nickel in vitro62,63. Nevertheless, the extent and biological rele-
vance for siderophores binding to other metals remains largely
unknown.
Most of the genes involved in Ybt biosynthesis are grouped in a
gene cluster64,65. In addition to Yersinia species, many Enter-
obacteriaceae also produce Ybt, including both pathogenic and
commensal E. coli46,66–68. Ybt is well known for scavenging iron
in vivo69, and plays a critical role in Y. pestis virulence64.
Moreover, Ybt reduces reactive oxygen species formation in
phagocytes by scavenging iron and preventing Haber-Weiss
reactions70, as well as contributes to intestinal fibrosis66, indi-
cating that Ybt modulates the host immune response.
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Incidentally, a product of the ybt gene cluster has been proposed
to enable zinc acquisition by Y. pestis40, although direct binding
of Ybt to zinc was not described in two independent studies39,41.
Our finding that pH influences binding of Ybt to zinc is likely a
key reason for the lack of binding that was observed in these prior
publications, as they did not assess changing the pH. Moreover,
reinterpretation of the original NMR and UV data in the afore-
mentioned studies does suggest that at least partial zinc coordi-
nation can be seen, as the data show slight UV and NMR shifts
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Fig. 4 The ability to acquire zinc via yersiniabactin enhances E. coli Nissle colonization of the inflamed gut. a Experiment timeline for the DSS-induced
colitis model and the administration of EcN strains. 8–10-week-old C57BL/6 female mice were given 4% (w/v) DSS in the drinking water for 4 days (day
−4 to 0). On day 0, mice were orally gavaged with 1 × 109 CFU of a 1:1 mixture of EcN strains. b, c Fecal samples were collected on day 1, 4, and 7, and the
competitive index (C.I.) was calculated by dividing the output ratio. b CFU of wild type or c of the znuA zupT strain / CFU of the competing double or triple
mutant strain in each group) by the CFU-enumerated input ratio of the strains. Two-sided one-sample t test was used on log-transformed data to accept or
reject null hypothesis (theoretical mean= 0) (black stars). Statistical significance between groups was determined by one-way ANOVA and Dunnett’s
multiple comparisons test of log-transformed data (red stars). d Cecal content was collected on day 7 and the C.I. of strains in the indicated groups was
calculated as described in b. Two-sided one-sample t test was used on log-transformed data to accept or reject null hypothesis (theoretical mean = 0).
e mRNA expression of S100a8, S100a9, and Lcn2 was measured in the colon of mice in panel c. f Colon pathology score of mice in panel d, with sub-scores
of each criterion (WT vs znuA zupT n= 8 samples; WT vs znuA zupT irp2 n= 10 samples; WT vs znuA zupT ybtX n= 5 samples; all colon samples are
biologically independent). g Representative stained sections (H&E, original magnification ×10, scale bars represent 250 μm) of distal colon from healthy or
DSS-treated mice administered with different groups of EcN; sample size as in f. b–e Each data point represents a single mouse (biologically independent
samples), and bars represent the geometric mean. The number (=n) of biologically independent replicates for each group is indicated in each figure panel.
f Data are presented as mean values ±SD. *P value≤ 0.05; **P value≤ 0.01; ***P value≤ 0.001; ****P value≤ 0.0001; ns not significant. Exact P values are
reported in Supplementary Data 2. Source data are provided as a Source Data file.
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to zinc. Nevertheless, a critical question remained as to the
identity of the molecule(s) produced by the Ybt gene cluster that
contributed to zinc acquisition and, in the context of our study,
whether such a molecule could play a role in gut colonization.
Using UHPLC-MS/MS, we identified two diastereomers of Ybt
from EcN wild-type supernatant extract that were not present in
the irp2 mutant supernatant; MS/MS spectra of both peaks
matched the MS/MS spectrum of commercial Ybt. Ybt is known
to isomerize at the C10 position (Fig. 3) into a racemic mixture49.
Using post-LC pH neutralization and metal infusion in a recently
developed workflow termed native metabolomics, we found that
one isomer (retention time= 4.0 min) preferentially binds zinc
(Fig. 2). The different affinity of siderophore diastereomers for a
metal is not unprecedented. Pyochelin, a siderophore with a
similar thiazoline core as Ybt and produced by Burkholderia
cepacia and several Pseudomonas strains, also exists as two dia-
stereomers, only one of which binds iron71. Moreover, although
pyochelin was shown to bind both iron and zinc in vitro72, to our
knowledge, the biological relevance of pyochelin-mediated zinc
scavenging has not been investigated. Similarly, only one of the
Ybt isomers was shown to bind gallium when the compound’s
structure was initially characterized49. We used 1D 1H NMR
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spectroscopy to confirm this observed zinc binding by Ybt
(Fig. 3). Specifically, we observed the loss of signal corresponding
to the two OH groups and the NH proton in Ybt, which indicates
the corresponding heteroatoms that chelate the Zn2+ ion.
Although the other zinc-coordinating atoms were not directly
characterized, we hypothesize that Ybt binds zinc in the same
manner as it binds iron and as micacocidin A binds Zn2+.
Because Ybt is known to bind iron, we performed a competi-
tion assay with equimolar amounts of zinc and iron. We observed
that the metal-binding preference of Ybt is pH-dependent – Ybt
preferentially binds to zinc in basic conditions (pH= 10), to iron
in acidic conditions (pH= 4), and exhibits similar preference for
both at pH 7 (Fig. 2e–g). In contrast to Ybt, the binding capacity
of pyochelin to different metals is pH independent72. We spec-
ulate that the pH-dependent metal selectivity of Ybt may confer
different functions to it under various physiological conditions
(e.g., inflammation or homeostasis), or different colonization
niches. For instance, in healthy human subjects, the pH in the
small intestine gradually increases from pH 6 in the duodenum to
about pH 7.4 in the terminal ileum, then drops to pH 5.7 in
the caecum, but again gradually increases, reaching pH 6.7 in the
rectum73. Upon inflammation, the pH in most sections of the
gastrointestinal tract further decreases, but the colon still pos-
sesses a higher pH than the small intestine and cecum. Because
dietary iron is mainly absorbed in the small intestine, the ability
of Ybt to bind iron at lower pH may enable EcN and other Ybt-
producing bacteria to compete with the host for iron in the small
intestine. On the other hand, the zinc-binding ability of Ybt may
enhance colonization of Ybt-producing bacteria in the colon,
where the pH is higher. Intriguingly, in patients with active
inflammatory bowel disease, the pH in many sections of the
intestine increases; for example, the terminal ileum has been
observed to reach up to pH 9.274.
During colitis, neutrophils are recruited to sites of inflamma-
tion and secrete high levels of CP to sequester zinc from invading
pathogens15,25,75. Our observation that Ybt renders EcN more
resistant than STm to zinc sequestration by CP (Fig. 1) in vitro
prompted us to investigate the function of Ybt during EcN
colonization of the inflamed gut. We found that EcN mutants
lacking either Ybt or the putative inner membrane receptor YbtX,
in addition to lacking ZnuABC and ZupT, showed more severe
colonization defects than the znuA zupT mutant in mice with
DSS-induced colitis (Fig. 4). As four other iron transport systems
(including the stealth siderophores salmochelin and aerobactin, as
well as heme uptake) are still present in these strains, it is unlikely
that the in vivo phenotype of the mutants is due to an inability to
overcome iron starvation. Consistent with this hypothesis, the
growth defect of the triple mutants (znuA zupT irp2 and znuA
zupT ybtX) in minimal media was only rescued by zinc supple-
mentation, but not by iron or nickel supplementation (Fig. 1).
Future studies with strains lacking Ybt in combination with other
iron or nickel acquisition systems are necessary to define the
contribution of Ybt for acquisition of these metals in vivo.
Together with the observations that Ybt contributes to optimal
growth of EcN in zinc-limited conditions in vitro (Fig. 1), and
that Ybt directly binds zinc at the pHs found in the intestine
(Fig. 2), the colonization defect of EcN znuA zupT irp2 and of
EcN znuA zupT ybtX in DSS-treated mice is consistent with the
strains’ limited ability to acquire zinc. Moreover, the colonization
advantage provided by Ybt is highly dependent on the state of
inflammation and presence of CP, as EcN znuA zupT and EcN
znuA zupT ybtX colonized to similar levels in S100a9−/− mice as
well as in germ-free mice (which lack inflammation and only
express low levels of CP) (Fig. 5). These results are in agreement
with the in vitro results showing that Ybt and the putative inner
membrane permease YbtX enable EcN to acquire zinc in media
supplemented with CP (Fig. 1). Our results are also in agreement
with prior work in Y. pestis showing that YbtX is involved in zinc
transport40.
Altogether, our work demonstrates that Ybt directly binds to zinc
in a pH-dependent manner, and that EcN can use Ybt to scavenge
zinc in physiologic, zinc-limiting in vitro conditions and in the
inflamed gut, thus overcoming CP-mediated zinc limitation. Broadly,
our study proposes that the role of Ybt and other siderophores may
be more complex than previously thought and may involve scaven-
ging zinc in the host. Because many commensal and pathogenic
Enterobacteriaceae (including Yersinia spp., E. coli, and Klebsiella
pneumoniae) produce Ybt, this important mechanism of zinc
acquisition in the gut may also play a role in other host tissues where
pathogens must scavenge zinc.
Methods
Bacterial strains, plasmids, and growth conditions. Bacterial strains and plasmids
are listed in Supplementary Table 1. Cultures of STm and E. coli were routinely
incubated either aerobically at 37 °C in Lysogeny broth (LB; per liter: 10 g tryptone, 5 g
yeast extract, 10 g NaCl) or on LB agar plates (1.5% Difco agar) overnight. Antibiotics
and other chemicals were added at the following concentrations (mg/L) as needed:
carbenicillin (Carb), 100; chloramphenicol (Cm), 30; kanamycin (Km), 50 or 100;
Fig. 5 Yersiniabactin-mediated zinc acquisition provides a competitive advantage for E. coli Nissle in the presence of inflammation and calprotectin. a
Experiment timeline for panels b and c. b, c Female Germ-free Swiss Webster mice were colonized with 1×109 CFU of a 1:1 mixture of b EcN znuA zupT and
znuA zupT irp2 (mice were 21 weeks of age) or c EcN znuA zupT and znuA zupT ybtX (mice were 30 weeks of age). Fecal samples were collected daily and
the competitive index (C.I.) was calculated by dividing the output ratio (CFU of EcN znuA zupT / CFU of the respective EcN triple mutant) by the CFU-
enumerated input ratio of the strains. Two-sided one-sample t test was used on log-transformed data to accept or reject null hypothesis (theoretical
mean= 0). d mRNA expression of S100a8, S100a9, and Lcn2 was measured in the cecum of mice in panel c (n= 5 biologically independent samples);
conventional DSS-treated mice colonized with EcN were used as a control (n= 5 biologically independent samples). Each circle represents a biologically
independent sample, and bars represent the geometric mean. Unpaired two-tailed t test was used. e Experiment timeline for panels f and g. f, g Male and
female S100a9-/- mice were given 4% (w/v) DSS in the drinking water for 4 days (day −4 to 0). On day 0, mice were orally gavaged with 1 × 109 CFU of a
1:1 mixture of f EcN znuA zupT and znuA zupT irp2 (mice were 9–10 weeks of age) or g EcN znuA zupT and znuA zupT ybtX (mice were 16–30 weeks of age).
Fecal samples were collected daily and the C.I. was calculated as described for panel b strains. Two-sided one-sample t test was used on log-transformed
data to accept or reject null hypothesis (theoretical mean= 0). b, c, f, g Each data point represents a single mouse (biologically independent samples), and
bars represent the geometric mean. The number (=n) of biologically independent replicates for each group is indicated in each figure panel. h mRNA
expression of Lcn2, Il17a, Tnfa, and Ifng was measured in the cecum of mice in panel f. Each circle (n= 5) represents a biologically independent sample, and
bars represent the geometric mean. i Representative stained sections (H&E, original magnification ×10, scale bars represent 250 μm) of colon from germ-
free mice, or DSS-treated S100a9−/− mice, 5–7 days post-administration of different groups of EcN (germ-free EcN znuA zupT vs znuA zupT irp2, n= 6;
germ-free EcN znuA zupT vs znuA zupT ybtX, n= 5; S100a9−/− mice EcN znuA zupT vs znuA zupT irp2, n= 6; S100a9−/− mice EcN znuA zupT vs znuA zupT
ybtX, n= 5; all colon samples are biologically independent). *P value≤ 0.05; **P value≤ 0.01; ***P value≤ 0.001, ns not significant. Exact P values are
reported in Supplementary Data 2. Source data are provided as a Source Data file.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-27297-2
10 NATURE COMMUNICATIONS |         (2021) 12:7016 | https://doi.org/10.1038/s41467-021-27297-2 | www.nature.com/naturecommunications
nalidixic acid (Nal), 50; and 5-bromo-4-choloro-3-indoyl-ß-D-galactopyranoside (Xgal),
40. For counterselection of pJK611, 10 % (w/v) sucrose was added to media.
E. coli Nissle 1917 mutant generation. Mutants in EcN and STm were con-
structed using either the lambda Red recombinase system or allelic exchange
deletion. To generate mutants with the lambda Red recombinase system76, primers
(Supplementary Table 2) homologous to sequences flanking the 5′ and 3′ ends of
the target regions were designed and were used to replace the selected genes with a
chloramphenicol (derived from pKD3), a kanamycin (derived from pKD4), or a
tetracycline resistance cassette (Supplementary Table 2). Strain names for the
mutants are listed in Supplemental Table 1. To confirm integration of the resis-
tance cassette and deletion of the target, mutant strains and wild-type controls were
each assayed utilizing PCR, and sequencing primers (Supplementary Table 2) that
flank the target sequence were used in conjunction with a common test primer to
test for both new junction fragments. E. coli Nissle 1917 wild type as well as
mutants znuA zupT, znuA zupT ybtX, and znuA zupT irp2 were sequenced to
confirm strain identity and to identify any unexpected mutations. Quality-control
metrics for next-generation sequencing data were obtained using FastQC. Raw
reads were aligned to the E. coli Nissle 1917 reference genome (Genbank accession
CP022686.1) using BWA MEM77. PCR duplicates were removed using Picard
MarkDuplicates78 to ensure that downstream results are not biased by PCR
duplication artifacts. Variants were discovered using freeBayes79, and Annovar80
was used to annotate variants with overlapping gene annotation information and
effect on gene and protein sequence, predicted effect on protein structure and
function, and previous observation of that variant in refGene database (Supple-
mentary Data 1).
Allelic exchange deletion of znuA in E. coli Nissle 1917. To construct an E. coli
Nissle 1917 (EcN; Supplementary Table 1) znuA mutant, DNA regions of
~600–800 bp in length flanking the znuA gene were amplified by PCR with primers
znuA FR1-Fw and znuA FR1-Rv (upstream flanking region, FR1) and primers
znuA FR2-Fw and znuA FR2-Rv (downstream flanking region, FR2). A BamHI
restriction site was added to the 5′ end of primers znuA FR1-Fw and znuA FR2-Rv,
and an XbaI restriction site was added to the 5′ end of primers znuA FR1-Rv and
znuA FR2-Fw (Supplementary Table 2). The blunt-end flanking region PCR pro-
ducts were digested with XbaI, then ligated together using the Quick Ligation kit
(New England Biolabs). Phusion High Fidelity DNA polymerase and primers znuA
FR1-Fw and znuA FR2-Rv were used to amplify the FR1+ FR2 ligation product
(FR1-FR2). A PCR product of the predicted size was gel-purified and ligated into
pCRBlunt II-TOPO using the ZERO Blunt cloning kit (Invitrogen). The construct
was heat-shocked into E. coli TOP10 and plated on LB+ Kan plates. Plasmids
isolated from single colonies were screened by EcoRI digestion, and positive clones
were confirmed by sequencing using M13 Fw and M13 Rv universal primers.
Accurate clones were designated pNM3 (pCRBlunt II-TOPO::znuA FR1-FR2). The
plasmid pNM3 was digested with BamHI, and the FR1-FR2 fragment was gel-
purified, ligated to BamHI-digested suicide vector pRDH10, then introduced into
chemically competent E. coli CC118 λpir cells by heat-shock followed by selection
on LB+ Cm agar. A positive clone was designated pNM4 (pRDH10::znuA FR1-
FR2). To enable conjugation of pNM4, purified plasmid was heat-shocked into E.
coli S17-1 λpir. Wild-type EcN carrying the temperature-sensitive plasmid
pSW17281 was conjugated with E. coli S17-1 λpir containing pNM4 on LB agar at
30 °C (to allow for pSW172 replication). Single-crossover transconjugants were
then selected for on LB+ Carb + Cm agar. Afterwards, the transconjugants were
subjected to sucrose selection in order to counterselect cells still harboring the
integrated pNM4 plasmid, thus yielding WT revertants or ΔznuA mutants.
Mutants were confirmed by PCR, then were cured of pSW172 by growth at 37 °C.
The resulting mutant strain was termed JZL95 (EcN ΔznuA(−82 to +1000)). An
EcN ΔznuA::KSAC strain was also generated (JZL109), first cloning the XbaI-
digested KSAC kanamycin resistance cassette from pBS34 into the XbaI restriction
site of pNM4, yielding pNM4::KSAC (pRDH10::znuA FR1-KSAC-FR2).
Construction of EcN znuA zupT mutant. The EcN znuA zupT mutant was con-
structed using the lambda Red recombinase system. Briefly, primers (zupT-Fw and
zupT-Rv) were designed with sequences homologous to the 5′ and 3′ ends of the
EcN zupT gene and sequences homologous to the kanamycin resistance cassette of
pKD4. The primers were used to PCR amplify the kanamycin resistance cassette.
The PCR product was gel-purified, then electroporated into EcN znuA (JZL95)
carrying pJK611 (a sucrose-counterselectable variant of pKD46). Kanamycin and
sucrose were used for selection of deletion mutants and counterselection of pJK611,
respectively. Putative mutants were screened on LB+ Carb agar to confirm loss of
pJK611, and the mutation was then confirmed using PCR. The resulting strain was
termed JZL100 (EcN ΔznuA(−82 to +1000) ΔzupT(−42 to +774)::Kan).
Construction of EcN ybtX, znuA ybtX, and znuA zupT ybtX mutants. EcN znuA
ybtX and EcN znuA zupT ybtX were constructed by allelic exchange, employing
EcN znuA (JZL109) and EcN znuA zupT (JZL100) as parental strains. Using the
NEBuilder tool (http://nebuilder.neb.com), overlapping primers were designed to
construct a deletion vector for the ybtX gene (−108 to +1281). In all, 1000 bp
upstream and downstream of the EcN ybtX gene, as well as the chloramphenicol
resistance cassette from pKD3, were amplified with the specific primers. Suicide
plasmid pGP704 was digested with EcoRV and SalI. PCR products and plasmids
were gel-purified, then equimolar concentrations were used in a Gibson Assembly
reaction, then transformed into E. coli CC118 λpir, selecting on LB+ Cm agar.
Clones were screened by sequencing the plasmid insert, and an accurate clone was
designated pJB10 (pGP704::ybtX FR1-Cm-FR2). pJB10 was then electroporated
into E. coli S17-1 λpir. EcN znuA and EcN znuA zupT were then separately
conjugated with E. coli S17-1 λpir pJB10 on LB agar, after which transconjugants
were selected for by plating on LB+ Kan+Cm agar. Double-crossover mutants
were identified by patching colonies on LB+ Carb and LB+ Cm plates. CarbS
CmR colonies were checked by PCR to assess for the loss of ybtX (ybtX_pres_Fw
and ybtX_pres_Rv) and the presence of the chloramphenicol resistance cassette
(Gib_out_LB_Fw and C2; Gib_out_RB_Rv and C1). The resulting strain EcN znuA
zupT ybtX was termed JB76, while EcN znuA ybtX was termed JB92. The EcN ybtX
mutant was constructed using the lambda Red system. Briefly, primers (ybtX_-
red_Fw and ybtX_red_Rv2) were designed with sequences homologous to the 5′
and 3′ ends of the EcN ybtX gene and to the chloramphenicol resistance cassette of
pKD3. The primers were used to amplify the chloramphenicol resistance cassette
by PCR. The PCR product was electroporated into EcN wild-type carrying pJK611.
Chloramphenicol and sucrose were used for selection of deletion mutants and
counterselection of pJK611, respectively. The mutation was confirmed using PCR,
and pJK611 was confirmed to be cured by plating on LB+ Carb agar. The resulting
strain was termed JB90 (EcN ΔybtX(−108 to +1281)::Cm).
Construction of EcN irp2 and EcN znuA zupT irp2 mutants. A mutant in EcN
carrying a deletion of the irp2 open reading frame was constructed using the
lambda Red system. Briefly, primers (irp2up-TetRA F and irp2dn-TetRA R) were
designed with sequences homologous to the 5′ and 3′ ends of the EcN irp2 gene
and to the tetRA resistance cassette of MSC74. The primers were used to amplify
the tetracycline resistance cassette by PCR. The PCR product was electroporated
into wild-type EcN containing pJK611. Tetracycline and sucrose were used for
selection of mutants and counterselection of pJK611, respectively. The irp2 deletion
was confirmed using PCR (irp2inF and irp2inR) and sequencing (irp2-upF and
irp2-dnR), and also confirmed for the loss of plasmid pJK611 by plating on
LB+Carb plates. The resulting strain was termed HZE116 (EcN Δirp2::Tet). A
deletion of the irp2 open reading frame in EcN znuA zupT (JZL100) was con-
structed by allelic exchange. Using the NEBuilder tool (http://nebuilder.neb.com),
overlapping primers were designed to construct a deletion vector for the irp2 gene.
500 bp upstream (pGP704-salI US irp2 F and TetR-US irp2 R) and downstream
(TetA-DS irp2 F and pGP704-sacI DS-irp2 R) regions of EcN flanking the irp2
gene, as well as the tetracycline resistance cassette (TetR-F and TetA-R) of MSC74,
were then amplified. Suicide plasmid pGP704 was digested with SalI and SacI. PCR
products and plasmid were gel-purified, then equimolar concentrations were used
in a Gibson Assembly reaction, followed by transformation into DH5α λpir and
selection on LB+ Tet agar. Clones were screened by sequencing, and an accurate
clone was designated pHZE107 (pGP704::ybtX FR1-Tet-FR2). pHZE107 was then
purified and electroporated into E. coli S17-1 λpir. EcN znuA zupT was conjugated
with E. coli S17-1 λpir pHZE107 on LB agar. Transconjugants were then selected
for by plating on LB+ Kan+Tet, and double-crossovers were identified by
screening for CarbS colonies. KanR TetR CarbS colonies were then tested by PCR
with primers checking for the loss of irp2 (irp2inF and irp2inR) and the presence of
the tetracycline resistance cassette (TetR-F and TetA-R). The resulting strain was
termed HZE112 (EcN znuA zupT irp2).
Bacterial Growth in LB, modified LB supplemented with calprotectin, and
M9 minimal medium. STm and EcN strains were tested for their ability to grow in
nutrient-rich conditions (LB), nutrient-limited conditions (M9 minimal medium
per liter; 6.8 g Na2HPO4, 3 g KH2PO4, 0.5 g NaCl, 1 g NH4Cl, 0.1 mM CaCl2, 1 mM
MgSO4, 0.2% glucose), and in modified LB supplemented with calprotectin (CP).
Bacteria were inoculated into M9 minimal medium from an LB agar plate, then
shaken overnight at 37 °C. Absorbance (λ= 600 nm) of the overnight cultures was
determined by spectrophotometry, 109 colony-forming units (CFU) were harvested
by centrifugation, washed with M9 medium twice, then serially diluted in M9. For
Fig. 1e, f, M9 additionally contained 1 mg/ml biotin and 1 mg/ml thiamin and
strains were grown in LB instead of M9 overnight. For growth assays, 5 µl of the
107 CFU/ml dilution were used to inoculate 95 μl of LB or M9. Cultures were
incubated for 24 h at 37 °C with shaking and growth was assessed at different time
points by CFU enumeration on agar plates. Growth was also tested in M9 minimal
medium supplemented with 5 μM ZnSO4, 5 μM FeCl2, or 5 μM NiCl2. 1 μM apo-
yersiniabactin (EMC Microcollections), or 1 μM apo-enterobactin (kindly provided
by Dr. Elizabeth Nolan, MIT). For growth in modified LB supplemented with CP,
10 µl of 105 CFU/ml was used to inoculate 90 μl of LB supplemented with CP buffer
(20 mM Tris pH 7.5, 100 mM β-mercaptoethanol, 3 mM CaCl2) and 125, 150 or
250 μg/ml wild-type CP, or 150 μg/ml Site I/II mutant CP (MU CP), respectively
(10:28:62 ratio of inoculum to LB media to CP buffer). CP was produced as
described previously37, and two batches were used for this study. Growth was
assessed by enumerating CFU on agar plates after incubating cultures statically for
16 h at 37 °C.
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Yersiniabactin standard sample preparation for MS. Yersiniabactin (acquired
from EMC Microcollections, https://www.microcollections.de/) stock solutions
were prepared by resuspension of the compound in ethanol to a concentration of
1 mM. A 20 µM solution was prepared for mass spectrometry (MS) analysis. Final
solutions for analysis were prepared in 50% methanol/50% water or in water +
0.1% formic acid (pH 2.8).
E. coli Nissle sample preparation for MS. Supernatants from wild-type and irp2
knockout E. coli Nissle cultures were extracted onto pre-washed SPE cartridges.
SPE cartridges were activated 3x with MeOH (3 × 3ml), then were washed 2x with
water+ 0.1% formic acid (3 × 3 ml). Sample was loaded dropwise (steady single
dripping) onto SPE cartridges, then cartridges were washed with water+ 0.1%
formic acid (3 × 3 ml). Sample was eluted into 1.9 ml MeOH, then this was con-
centrated by speed evaporation at room temperature. Samples were weighed and
reconstituted with 80% MeOH/20% water+ 0.1% FA to a final concentration of
1 mg/ml. 5 µl of sample were injected per run.
Direct Inject-MS data acquisition. For MS analysis, 5 µl were injected through
a Vanquish UHPLC system into a Q Exactive Orbitrap mass spectrometer
(Thermo Fisher Scientific, Bremen, Germany). A flow rate between 0.2 ml/min and
0.4 ml/min was used for experiments. Data acquisition was performed in MS1 in
positive mode. Electrospray ionization (ESI) parameters were set to 52 L/min
sheath gas flow, 14 L/min auxiliary gas flow, 0 L/min sweep gas flow, and 400 °C
auxiliary gas temperature. The spray voltage was set to 3.5 kV and the inlet
capillary to 320 °C. 50 V S-lens level was applied. MS scan range was set to
150–1500 m/z with a resolution at m/z 200 (Rm/z 200) of 35,000 with one micro-
scan. The maximum ion injection time was set to 100 ms with an automated gain
control (AGC) target of 1.0E6.
UHPLC-MS/MS data acquisition. For LC-MS/MS analysis, 5 µl were injected into
a Vanquish UHPLC system coupled to a Q Exactive Orbitrap mass spectrometer
(Thermo Fisher Scientific, Bremen, Germany). For the chromatographic separa-
tion, a C18 porous core column (Kinetex C18, 50 × 2 mm, 1.8 μm particle size, 100
Angstrom pore size, Phenomenex, Torrance, USA) was used. For gradient elution,
a high-pressure binary gradient system was used. The mobile phase consisted of
solvent A (H2O+ 0.1% FA) and solvent B (acetonitrile+ 0.1% FA). The flow rate
was set to 0.5 ml/min. After injection, the samples were eluted with the following
linear gradient: 0–0.5 min 5% B, 0.5–5 min 5–99% B, followed by a 2 min washout
phase at 99% B and a 3 min re-equilibration phase at 5% B. Data-dependent
acquisition (DDA) of MS/MS spectra was performed in positive mode. ESI para-
meters were set to 52 L/min sheath gas flow, 14 L/min auxiliary gas flow, 0 L/min
sweep gas flow, and 400 °C auxiliary gas temperature. The spray voltage was set to
3.5 kV and the inlet capillary to 320 °C. 50 V S-lens level was applied. MS scan
range was set to 150–1500 m/z with a resolution at m/z 200 (Rm/z 200) of 35,000
with one micro-scan. The maximum ion injection time was set to 100 ms with an
AGC target of 1.0E6. Up to 5 MS/MS spectra per MS1 survey scan were recorded in
DDA mode with Rm/z 200 of 17,500 with one micro-scan. The maximum ion
injection time for MS/MS scans was set to 100 ms with an AGC target of 3.0E5 ions
and minimum 5% C-trap filling. The MS/MS precursor isolation window was set to
m/z 1. Normalized collision energy was set to a stepwise increase from 20 to 30 to
40% with z= 1 as default charge state. MS/MS scans were triggered at the apex of
chromatographic peaks within 2 to 15 s from their first occurrence. Dynamic
precursor exclusion was set to 5 s. Ions with unassigned charge states were excluded
from MS/MS acquisition as well as isotope peaks.
Post LC-MS/MS pH neutralization and metal addition for native spray mass
spectrometry. A stock solution of 160 mM Zn(CH3CO2)2 was prepared, then
diluted to a final concentration of 3.2 mM. A stock solution of ammonium
hydroxide at 1 M was also prepared. Sample was run through a C18 column at a
flow rate of 0.5 ml/min. Before electrospray, a neutralizing solution of 1M
ammonium hydroxide was added at a flow rate of 5 μl/min, then the solution of
3.2 mM zinc acetate was added at a flow rate of 5 μl/min. Post-LC pH was verified
by collecting the flow through and spotting on pH paper (Sigma).
Ion identity molecular networking of wild-type E. coli Nissle supernatant
extracts with post-LC zinc infusion. MS was run as described in the LC-MS/MS
data acquisition section. MS/MS spectra were converted to.mzML files using MScon-
vert (ProteoWizard)82. All raw and processed data is publicly available at https://
massive.ucsd.edu/ProteoSAFe/dataset.jsp?task=cf9f1c6478964a6f9464006b7aa9bd49.
MS1 feature extraction and MS/MS pairing was performed with MZMine
2.37corr17.7_kai_merge234,83,84. An intensity threshold of 1E6 for MS1 spectra and of
1E3 for MS/MS spectra was used. MS1 chromatogram building was performed within a
10 ppm mass window and a minimum peak intensity of 3E5 was set. Extracted Ion
Chromatograms (XICs) were deconvoluted using the local minimum search algorithm
with a chromatographic threshold of 0.01%, a search minimum in RT range of 0.1min,
and a median m/z center calculation with m/z range for MS2 pairing of 0.01 and RT
range for MS2 scan pairing of 0.2. After chromatographic deconvolution, MS1 features
linked to MS/MS spectra within 0.01m/z mass and 0.2min retention time windows.
Isotope peaks were grouped and features from different samples were aligned with
10 ppm mass tolerance and 0.1min retention time tolerance. MS1 peak lists were
joined using an m/z tolerance of 10 ppm and retention time tolerance of 0.1min;
alignment was performed by placing a weight of 75 on m/z and 25 on retention time.
Gap filling was performed using an intensity tolerance of 10%, an m/z tolerance of
10 ppm, and a retention tolerance of 0.1. Correlation of co-eluting features was per-
formed with the metaCorrelate module; retention time tolerance of 0.1, minimum
height of 1E5, noise level of 1E4 were used. A correlation of 85 was set as the cutoff for
the min feature shape corr. The following adducts were searched: [M+H+]+,
[M+Na+]+, [M+K+]+, [M+Ca2+]2+, [M+ Zn2+- H+]+, and [M-H2O], with an
m/z tolerance of 10 ppm, a maximum charge of 2, and maximum molecules/cluster of
2. Peak areas and feature correlation pairs were exported as.csv files and the corre-
sponding consensus MS/MS spectra were exported as an.mgf file. For spectral net-
working and spectrum library matching, the.mgf file was uploaded to the feature-based
molecular networking workflow on GNPS (gnps.ucsd.edu)47,48,85. For spectrum library
matching and spectral networking, the minimum cosine score to define spectral
similarity was set to 0.7. The Precursor and Fragment Ion Mass Tolerances were set to
0.01Da and Minimum Matched Fragment Ions to 4, Minimum Cluster Size to 1 (MS
Cluster off). When Analog Search was performed, the maximum mass difference was
set to 100 Da. The GNPS job for the siderophore mix can be accessed: https://
gnps.ucsd.edu/ProteoSAFe/status.jsp?task=525fd9b6a9f24455a589f2371b1d9540.
All.csv and.mgf files in addition to MZmine 2 project can be accessed at https://
massive.ucsd.edu/ProteoSAFe/dataset.jsp?task=cf9f1c6478964a6f9464006b7aa9bd49.
Mgf files were exported for SIRIUS in MZmine2, then molecular formulas were
determined using SIRIUS 4.0.1 (build 9)86 and molecular formulas can be accessed:
http://gnps.ucsd.edu/ProteoSAFe/status.jsp?task=e2bd16458ec34f3f9f99982dedc7d158.
Metal competition MS experiments. Commercial yersiniabactin (dissolved to
1 mM in ethanol) was added to 10 mM ammonium acetate buffer at a defined pH
(as determined by pH meter, Denver Instrument UltraBasic) for a final con-
centration of 10 µM. Acetic acid was added to the buffer to lower the pH to 4, and
ammonium hydroxide was added to the buffer to raise the pH to 10. Solutions of
zinc acetate and iron chloride were prepared to a final concentration of 10 mM in
water; from this solution, both iron and zinc were added to a final solution of
100 µM.
Yersiniabactin/calprotectin competition assay. 2 mg of calprotectin and
mutant-calprotectin in 200 μL buffer A (20 mM Tris pH 7.5, 100 mM β-mercap-
toethanol, 3 mM CaCl2) were exchanged into 10 mM ammonium acetate buffer
using Amicon Ultra 3k filters (14,000×g for 15 mins, 3x). Calprotectin and mutant-
calprotectin were reconstituted in a 10 mM ammonium acetate buffer to a final
concentration of 4 mg/mL. Then calprotectin and mutant-calprotectin were incu-
bated with 168 μM ZnSO4 (or water vehicle) for 90 mins at a 1:1 ratio (calprotectin
contains 2 zinc-binding sites). Yersiniabactin was incubated with 100 μM ZnSO4
(or water vehicle) then was added to calprotectin (or mutant-calprotectin) at a final
ratio of 2:1 protein to yersiniabactin. This was incubated overnight at 4 °C, then
yersiniabactin was separated from protein using Amicon Ultra 3k filters (14,000×g
for 30 mins) by collecting the flowthrough. Flowthrough was run using direct
infusion mass spectrometry in technical duplicate. For MS analysis, 5 µL of flow-
through were directly infused into a Q-Exactive orbitrap mass spectrometer via
flow injections through a Vanquish UHPLC system (Thermo Fisher Scientific,
Bremen, Germany). A flow rate of 0.15 mL/min was used. MS1 data acquisition
was performed in positive mode. Electrospray ionization (ESI) parameters were set
to 53 L/min sheath gas flow, 14 L/min auxiliary gas flow, 0 L/min sweep gas flow,
and 400 °C auxiliary gas temperature. The spray voltage was set to 3.5 kV and the
inlet capillary to 320 °C. 50 V S-lens level was applied. MS scan range was set to
200–2000 m/z with a resolution at m/z 200 (Rm/z 200) of 70,000 with one micro-
scan. The maximum ion injection time was set to 200 ms with an automated gain
control (AGC) target of 3.0E6. Peak area was integrated using Quant Browser in
Thermo XCalibur software, and data was visualized using GraphPad Prism 9.
NMR experiments and signal assignments. All NMR experiments were per-
formed on a Varian 500MHz spectrometer equipped with a 1H channel cold-
probe. The yersiniabactin (Ybt, 0.25 mg) sample was dissolved in deuterated
acetonitrile (CD3CN, 300 µl). The NMR spectra were acquired at 298 K in 3-mm
NMR tubes and raw data were processed using Bruker Topspin version 4.0.7. The
1H peaks resonance assignments were made using a combination of 2D COSY
(Supplementary Fig. 2b), 2D ROESY with a mixing time of 300 ms (Supplementary
Fig. 2c). The assignments were made with the assistance of NMRFAM-SPARKY.
The 1D experiments were acquired with a relaxation delay of 1 s, 90° 1H pulses of
about 9.0 µs, and a spectral width of 8000 Hz. 2D ROESY spectra were acquired
with a spinlock of 200–300 ms, using 128 transients per FID, and 128 points in the
indirect dimension.
Zn binding and base titration for NMR studies. 1D 1H NMR titration experi-
ments were carried out to investigate the binding of Zn2+ (added as ZnCl2) to Ybt.
Ybt (0.25 mg) was dissolved in deuterated acetonitrile (CD3CN, 300 μl) then a
baseline spectrum was taken. A spectrum was recorded between each addition of
ZnCl2. 0.5 equiv. of ZnCl2 dissolved in CD3CN was added to the dissolved Ybt,
followed by a second 0.5 equiv. (1 equiv. total), another 1 equiv. (2 equiv. total),
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and finally another 3 equiv. (5 equiv. total). Once the spectrum with 5 equiv. of
ZnCl2 was recorded, an NaOD (in D2O) titration was performed to determine the
effect of increasing pH on the binding of Zn2+. Sequential additions of 0.5 equiv., a
second 0.5 equiv., 1 equiv., and 3 equiv. were made and 1D 1H NMR spectra were
recorded for each titration point.
Mouse experiments. Germ-free Swiss Webster mice as well as specific pathogen-
free C57BL/6 wild-type mice and S100a9−/− mice were used in our study, in
accordance with protocols and guidelines approved by the Institutional Animal
Care and Use Committee of the University of California, Irvine (2009-2885; 2009-
2872; 2015-3159) and the University of California, San Diego (S17107), and the
University of Illinois, Chicago (20-016). C57BL/6 mice were purchased from the
Jackson Laboratory, whereas S100a9−/− mice87 were bred in-house. Mice at UC
Irvine and at UC San Diego were fed diet Teklad 2920X. Germ-free Swiss Webster
mice were purchased from Taconic Farms and then bred in-house in germ-free
isolators (Park Bio). These mice were fed irradiated diet Purina 5066. The mice
were kept in a 12 h light/dark cycle, at a room temperature of ~22 °C and ~52%
humidity. For experiments, germ-free mice were transferred to sterile housing
inside a biosafety cabinet, then colonized with the respective bacterial strains. For
chemical colitis experiments using dextran sodium sulfate (DSS), mice were
administered 4% (w/v) DSS (MP Biomedicals) in the drinking water beginning
4 days prior to administering bacteria, then provided a fresh 4% DSS solution one
day prior. On the day of inoculation, mice were switched to 2% (w/v) DSS in the
drinking water and orally gavaged with 1×109 CFU of a mixture of strains at a 1:1
ratio, as indicated. A fresh 2% DSS solution was provided on day 4 post-
inoculation. At day 5 or 7 post-inoculation, depending on weight loss, mice were
humanely euthanized. Fecal content was collected on days 1, 4, and 5 or 7, whereas
cecal content was collected directly during necropsy at day 7. CFU were enum-
erated by plating on appropriate selective agar media. In all mixed inoculation
experiments, the competitive index of the EcN strains used in each group were
calculated. Groups of 5–10 male and female mice were used for each experiment.
Quantitative real-time PCR. Total RNA was extracted from cecal and colon tis-
sues of wild-type mice, or cecal tissues of germ-free mice, with TRI Reagent
(Sigma-Aldrich), followed by processing with an RNeasy Mini Plus kit (Qiagen).
For analyzing gene expression by quantitative real-time PCR, cDNA from each
RNA sample was prepared with the SuperScript IV VILO Master Mix with ezD-
Nase kit (ThermoFisher). Real-time qPCR was performed with PowerUp SYBR
Green Master Mix (ThermoFisher) and a QuantStudio 5 (ThermoFisher). Data
were analyzed using the comparative 2−ΔΔCt method. Target gene expression in
each tissue sample was normalized to the respective levels of Actb mRNA (β-actin),
and compared to uninfected samples.
Histopathology. Distal colonic tissues from wild-type mice, proximal colonic
tissues from S100a9−/− mice, and proximal colonic tissues from germ-free mice
were fixed in 10% buffered formalin, then processed according to standard pro-
cedures for paraffin embedding. 5 µm sections were stained with hematoxylin and
eosin, then slides were scanned on a NanoZoomer Slide scanner (Hamamatsu) and
scored in a blinded fashion as previously described3, with minor modifications.
Briefly, each of four histological criteria (mononuclear infiltration, edema, epi-
thelial injury, and neutrophilic inflammation/crypt abscesses) was determined as
absent (0), mild (1), moderate (2), or severe (3). Furthermore, each parameter was
assigned an extent factor reflecting its overall involvement ranging from 1 (<10%),
2 (10–25%), 3 (25–50%), and 4 (>50%). Scores represent the sum of the above
scores in colon sections.
Statistics. Statistical analysis was performed with GraphPad Prism 9. CFU data
were transformed to Log10 and passed a normal distribution test before running
statistical analyses. CFU from in vitro growth experiments were compared by one-
way ANOVA (Fig. 1c, g) or two-way ANOVA (Fig. 1d) followed by Tukey’s
multiple comparisons test, two-way ANOVA with Šidák’s multiple comparisons
test (Fig. 1a, b), or one-sample t test (Supplementary Fig. 1a–e). Mouse experiments
were analyzed with one-sample t test. Values were transformed to Log10 and
compared to a hypothetical mean of 0. For comparison between groups,
one-way ANOVA followed by Dunnet’s multiple comparisons test was used.
An adjusted P value ≤ 0.05 was considered statistically significant. *P value ≤ 0.05,
**P value ≤ 0.01, ***P value ≤ 0.001, ****P value ≤ 0.0001. For qPCR data ana-
lysis, a multiple t-test was performed on gene expression levels between the groups;
* indicates a P value ≤ 0.05, **P value ≤ 0.01. Exact P values are reported in
Supplementary Data 2.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Source Data for figures and all NMR raw data are provided with this paper. For genome
analysis, we used the E. coli Nissle 1917 wild-type strain reference genome (GenBank
CP022686.1). All mass spectrometry.raw and centroid.mzXML or.mzML files, in addition
to MZmine 2 outputs and project file, are publicly available in the mass spectrometry
interactive virtual environment (MassIVE) under massive.ucsd.edu with project identifier
MSV000083387 (E. coli Nissle siderophores); raw spectra of yersiniabactin commercial
standards are available under MSV000084237 (Siderophore Standard Mixture with metal
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